Description
A class I (IC50s = 3.7, 7.4, 0.42, and 2.8 μM for HDAC1, -2, -3, and -8, respectively) and class II HDAC inhibitor (IC50s = 3.1, 0.1, 3.1, and 4.2 μM for HDAC4, -6, -7, and -10, respectively); selective for class I and II HDACs over class III HDACs (IC50s = >30 μM for SIRT1, SIRT2, and SIRT3) and the histone acetyltransferase PCAF (IC50 = >30 μM); at 48 hours post-infection, increases replication of oHSV in MDA-MB-231 and 4T1 breast cancer cells at 10 and 50 μM prior to viral infection
Formal name: N-hydroxy-3-[1-methyl-4-(2-phenylacetyl)-1H-pyrrol-2-yl]-2-propenamide
Synonyms: MC 1353
Molecular weight: 284.3
CAS: 676599-90-9
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Small Molecule Inhibitors|Deacetylases||Research Area|Cancer||Research Area|Epigenetics, Transcription, & Translation|Erasers|Histone Deacetylation